scholarly article | Q13442814 |
P50 | author | André Russowsky Brunoni | Q37838852 |
Felipe Fregni | Q94208845 | ||
P2860 | cites work | Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis | Q21143851 |
A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression | Q24605929 | ||
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications | Q24649095 | ||
Transcranial direct current stimulation in severe, drug-resistant major depression | Q28238164 | ||
The meaning of translational research and why it matters | Q28264016 | ||
Treatment of major depression with transcranial direct current stimulation | Q28302459 | ||
Reporting methods of blinding in randomized trials assessing nonpharmacological treatments | Q28469142 | ||
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report | Q29615999 | ||
No benefit derived from repetitive transcranial magnetic stimulation in depression: a prospective, single centre, randomised, double blind, sham controlled "add on" trial | Q30495454 | ||
Add-on rTMS for treatment of depression: a pilot study using stereotaxic coil-navigation according to PET data | Q30797011 | ||
Placebo treatment versus no treatment | Q30882137 | ||
Sham interventions in randomized clinical trials of acupuncture--a review. | Q33199606 | ||
What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials | Q33285571 | ||
CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration | Q33316156 | ||
Do medical devices have enhanced placebo effects? | Q34003166 | ||
The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial | Q34348362 | ||
Type-II Error Rates (Beta Errors) of Randomized Trials in Orthopaedic Trauma | Q34433541 | ||
Adaptive two-stage designs in phase II clinical trials | Q34494735 | ||
Is this patient clinically depressed? | Q34552378 | ||
Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder | Q34587328 | ||
Methodological issues in current antipsychotic drug trials | Q34587745 | ||
Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis | Q34591323 | ||
Technology insight: noninvasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS. | Q34646129 | ||
A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression | Q34815480 | ||
Repetitive transcranial magnetic stimulation : does it have potential in the treatment of depression? | Q35107729 | ||
Acceleration and augmentation strategies for treating bipolar depression | Q35111584 | ||
Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis | Q35141247 | ||
Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials | Q35648461 | ||
Special issues in the management of depression in older patients | Q35775181 | ||
A review of two journals found that articles using multivariable logistic regression frequently did not report commonly recommended assumptions. | Q35965374 | ||
Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects | Q36093733 | ||
Common pitfalls in the conduct of clinical research | Q36337343 | ||
Major depressive disorder: remission of associated symptoms. | Q36539443 | ||
Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation | Q36580793 | ||
Clinical trial design issues: at least 10 things you should look for in clinical trials | Q36599365 | ||
Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities | Q36637666 | ||
Initiatives to promote the discovery of drugs to improve cognitive function in severe mental illness | Q36654293 | ||
Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. | Q36694600 | ||
The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder | Q36760626 | ||
Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies | Q36892838 | ||
Fact: antidepressants and anxiolytics are not safe during pregnancy | Q36896153 | ||
Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment | Q37144258 | ||
Can the 'yin and yang' BDNF hypothesis be used to predict the effects of rTMS treatment in neuropsychiatry? | Q37146815 | ||
Adaptive design methods in clinical trials - a review | Q37153817 | ||
Combining proof-of-concept with dose-finding: utilization of adaptive designs in migraine clinical trials | Q37177502 | ||
Effect of transcranial magnetic stimulation on Parkinson motor function--systematic review of controlled clinical trials | Q37313214 | ||
Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia | Q37356411 | ||
The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies | Q37385212 | ||
Rating scales for mood disorders: applicability, consistency and construct validity | Q39562598 | ||
Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation | Q40529955 | ||
Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial | Q42594635 | ||
Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment | Q45055727 | ||
Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study | Q45225960 | ||
Myoinositol content in the human brain is modified by transcranial direct current stimulation in a matter of minutes: a 1H-MRS study. | Q46347393 | ||
A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression | Q46684565 | ||
Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial | Q46724830 | ||
A double-blind sham controlled study of right prefrontal repetitive transcranial magnetic stimulation (rTMS): therapeutic and cognitive effect in medication free unipolar depression during 4 weeks | Q46768542 | ||
Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial. | Q46885742 | ||
Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial | Q48173475 | ||
Antidepressant effects of high and low frequency repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex: a double-blind, randomized, placebo-controlled trial | Q48205392 | ||
Antidepressant efficacy of two different rTMS procedures. High frequency over left versus low frequency over right prefrontal cortex compared with sham stimulation | Q48284518 | ||
Lack of a therapeutic effect of a 2-week sub-threshold transcranial magnetic stimulation course for treatment-resistant depression | Q48398082 | ||
Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression | Q48405251 | ||
Transcranial DC stimulation (tDCS): a tool for double-blind sham-controlled clinical studies in brain stimulation | Q48679577 | ||
Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trial | Q48729403 | ||
Add-on rTMS for medication-resistant depression: a randomized, double-blind, sham-controlled trial in Chinese patients | Q48806139 | ||
A sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depression | Q50915417 | ||
Effect of age, gender, menopausal status, and ovarian hormonal level on rTMS in treatment-resistant depression | Q51702962 | ||
An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refractory depression: reproducibility and duration of the antidepressant effect in medication-free patients. | Q51890399 | ||
Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients | Q51941066 | ||
Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study | Q51943422 | ||
Treatment of Vascular Depression Using Repetitive Transcranial Magnetic Stimulation | Q60619364 | ||
Adjunctive fast repetitive transcranial magnetic stimulation in depression | Q60621641 | ||
Antidepressant effects of augmentative transcranial magnetic stimulation | Q60636619 | ||
A Randomized, Controlled Trial of Sequential Bilateral Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression | Q60732619 | ||
A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression | Q62612282 | ||
Psychiatric diagnosis in clinical practice: is comorbidity being missed? | Q77849031 | ||
Patients with a major depressive episode responding to treatment with repetitive transcranial magnetic stimulation (rTMS) are resistant to the effects of rapid tryptophan depletion | Q79387918 | ||
Long-lasting effects of high frequency repetitive transcranial magnetic stimulation in major depressed patients | Q79781376 | ||
Repetitive transcranial magnetic stimulation (rTMS) in major depressive episode during pregnancy | Q80727606 | ||
A 3-month, follow-up, randomized, placebo-controlled study of repetitive transcranial magnetic stimulation in depression | Q80876894 | ||
High (20-Hz) and low (1-Hz) frequency transcranial magnetic stimulation as adjuvant treatment in medication-resistant depression | Q81630976 | ||
P433 | issue | 2 | |
P304 | page(s) | e19-30 | |
P577 | publication date | 2011-06-01 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | International Journal of Methods in Psychiatric Research | Q15752770 |
P1476 | title | Clinical trial design in non-invasive brain stimulation psychiatric research | |
P478 | volume | 20 |
Q35967943 | A Randomised Controlled Trial of Neuronavigated Repetitive Transcranial Magnetic Stimulation (rTMS) in Anorexia Nervosa |
Q33669292 | Anodal transcranial direct current stimulation over the left dorsolateral prefrontal cortex modulates attention and pain in fibromyalgia: randomized clinical trial |
Q47843157 | Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression |
Q48413702 | Bench to clinical translational applications of noninvasive brain stimulation |
Q35240539 | Bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis of randomized controlled trials |
Q38080645 | Blinding integrity in randomized sham-controlled trials of repetitive transcranial magnetic stimulation for major depression: a systematic review and meta-analysis |
Q36542983 | Changes in resting state functional connectivity after repetitive transcranial direct current stimulation applied to motor cortex in fibromyalgia patients |
Q36344084 | Clinical outcomes and neural correlates of 20 sessions of repetitive transcranial magnetic stimulation in severe and enduring anorexia nervosa (the TIARA study): study protocol for a randomised controlled feasibility trial |
Q35722828 | Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions |
Q46263734 | Differential improvement in depressive symptoms for tDCS alone and combined with pharmacotherapy: an exploratory analysis from the Sertraline vs. Electrical Current Therapy for Treating Depression Clinical Study |
Q90115415 | Effects of Transcranial Direct Current Stimulation (tDCS) and Approach Bias Modification (ABM) training on food cravings in people taking antipsychotic medication |
Q51738665 | Effects of transcranial direct current stimulation on working memory and negative symptoms in schizophrenia: a phase II randomized sham-controlled trial. |
Q48214398 | Feasibility of focal transcranial DC polarization with simultaneous EEG recording: preliminary assessment in healthy subjects and human epilepsy. |
Q38947418 | Freezing of gait in Parkinson's disease: from pathophysiology to emerging therapies. |
Q39211451 | Impact of two or less missing treatment sessions on tDCS clinical efficacy: results from a factorial, randomized, controlled trial in major depression |
Q48390036 | Neural correlates of clinical improvement after deep transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a case report using functional magnetic resonance imaging |
Q37429825 | Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability |
Q47685472 | PsychotherapyPlus: augmentation of cognitive behavioral therapy (CBT) with prefrontal transcranial direct current stimulation (tDCS) in major depressive disorder-study design and methodology of a multicenter double-blind randomized placebo-controlle |
Q90353616 | Repetitive transcranial magnetic stimulation significantly influences the eating behavior in depressive patients |
Q49340310 | Rigor and reproducibility in research with transcranial electrical stimulation: An NIMH-sponsored workshop |
Q36445094 | Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS |
Q38106491 | Therapeutic time window of noninvasive brain stimulation for pain treatment: inhibition of maladaptive plasticity with early intervention |
Q28269400 | Transcranial magnetic stimulation in autism spectrum disorder: Challenges, promise, and roadmap for future research |
Q90344570 | Trends of Repetitive Transcranial Magnetic Stimulation From 2009 to 2018: A Bibliometric Analysis |
Q34200587 | tDCS-induced analgesia and electrical fields in pain-related neural networks in chronic migraine |
Search more.